# Topiramate

## Trokendi XR 50mg

#### 一般可用

| 藥品代碼       | OTRO                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|:---------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Migraine prophylaxis. Epilepsy monotherapy or adjuvant therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 用法用量       | Partial seizure or primary generalized tonic-clonic seizure， Initial monotherapy: 10 years older: First week， 50 mg orally once daily; second week， 100 mg once daily; third week， 150 mg once daily; fourth week， 200 mg once daily; fifth week， 300 mg once daily; sixth week and thereafter， 400 mg once daily. 6-10 years old: Initial， 25 to 50 mg orally once daily; may increase by 25 to 50 mg/day at 1-week intervals to usual maintenance dose of 200 to 400 mg/day. Minimum and maximum maintenance dose: 11kg or less: 150-250 mg/day; 12-22kg: 200-300 mg/day; 23-31kg: 200-350 mg/day; 32-38kg: 250-350 mg/day; up to 38kg: 250-400 mg/day. Partial seizure， primary generalized tonic-clonic seizure or Lennox-Gastaut syndrome， Adjunct: 6 to 16 years: Initial， 25 mg orally (1 to 3 mg/kg/day) once daily at nighttime for 1 week; increase by 1 to 3 mg/kg/day at 1- to 2-week intervals to achieve optimal response; maintenance， 5 to 9 mg/kg/day. 17 years or older: Initial， 25 to 50 mg orally once daily; may increase by 25 to 50 mg/day at 1-week intervals to usual maintenance dose of 200 to 400 mg/day. Migraine prophylaxis: 12 years or older: Initial， 25 mg orally once daily at nighttime for 1 week; titration， increase by 25 mg/day in weekly intervals to 100 mg/day， longer titration intervals may be used; dosage and titration rate should be based on clinical outcome. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌           | Recent alcohol use within 6 hours prior to or 6 hours after topiramate use. Metabolic acidosis with concomitant metformin use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 副作用         | Common Dermatologic: Flushing (Pediatric， 5% ) Endocrine metabolic: Serum bicarbonate level abnormal (25% to 67% ) Gastrointestinal: Loss of appetite (10% to 24% )， Weight decreased (4% to 21% ) Immunologic: Infectious disease (2% to 8% ) Neurologic: Confusion (3% to 11% )， Dizziness (4% to 25% )， Impaired cognition (2% to 7% )， Impaired psychomotor performance (2% to 13%)， Memory impairment (3% to 12% )， Paresthesia (1% to 51% )， Reduced concentration span (2% to 10% )， Somnolence (6% to 29% ) Psychiatric: Feeling nervous (4% to 16% )， Mood disorder (4% to 11% ) Other: Fatigue (6% to 16% )， Fever (1% to 12% ) Serious Dermatologic: Erythema multiforme， Stevens-Johnson syndrome， Toxic epidermal necrolysis Endocrine metabolic: Hyperammonemia (Adolescent， 26% )， Hypohidrosis， Increased body temperature， Metabolic acidosis (Adult， 14% to 44%; pediatric， 9% to 77% ) Hepatic: Liver failure Neurologic: Drug-induced encephalopathy Ophthalmic: Angle-closure glaucoma， Glaucoma， Myopia， Visual field defect (Epilepsy， 0.1% to 1% ) Psychiatric: Suicidal thoughts Renal: Nephrolithiasis (Adult， 1% to 3% ) Other: Withdrawal symptom                                                                                                                                                                                                                                |
| 孕期用藥建議   | Human (and animal) data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

